Lymphedema Diagnostics Market Research, Size, Growth, Revenue Share Analysis, and Forecast To 2030
The Lymphedema Diagnostics
Market is projected to
reach USD 30.29 Million by 2030 at 7.5% CAGR during the forecast period
2022-2030.
Lymphatic
obstruction or lymphedema is a long-term condition where the excess fluid forms
in the body tissue and causes swelling commonly called edema. It develops due
to the damaged lymphatic system. Sometimes it also develops after the treatment
of breast cancer.
The growth
of the global lymphedema diagnostics market is determined by numerous factors
such as increasing incidence of cancer, high prevalence of lymphedema, and the
adoption of new diagnostic modalities. However, the short half-life of
radiopharmaceuticals and the high cost of diagnostic tests is projected to
restrain the growth of the market during the forecast period.
The global
lymphedema diagnostics market is currently dominated by several market players.
The key players are involved in expansion, acquisition, and strategic
collaborations to strengthen their market positions.
Regional
Analysis
The lymphedema
diagnostics market research has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The
Americas is anticipated to hold the largest market share owing to the high
prevalence of lymphedema, well-established healthcare sector, and presence of
the prominent players in this region. The lymphedema diagnostics market in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada.
The
European lymphedema diagnostics market has been categorized as Western Europe
and Eastern Europe. The Western European market has further been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The
lymphedema diagnostics market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
rising prevalence of cancer and the expansion of healthcare facilities, the
market in Asia-Pacific is expected to be the fastest-growing. The lymphedema
diagnostics market in the Middle East & Africa has been divided into the Middle
East and Africa.
Segmentation
The global
lymphedema diagnostics market has been segmented based on type, technology,
disease type, and end user.
The market,
based on type, has been divided into primary and secondary. The secondary
lymphedema is likely to hold maximum market share in the global lymphedema
diagnostics market owing to the large population related to the secondary
lymphedema presence across the globe.
The global
lymphedema diagnostics market based on technology has been segregated into lymphoscintigraphy,
magnetic resonance imaging, computed tomography, ultrasound imaging, and
others. The lymphoscintigraphy segment is anticipated to hold the largest share
in the market due to the large preference for the test.
The global
lymphedema diagnostics market based on disease type has been segregated into
cancer, inflammatory diseases, cardiovascular disease, and others. The cancer
segment is anticipated to hold the largest share in the market as a cancer
treatment is one of the major factors causing lymphedema.
The
end-user segments of the market are hospitals, diagnostic centers, and others.
The hospital's segment is expected to hold the largest share of the market, as
these are the primary locations where patients receive lymphedema treatment & diagnosis.
Key
Players
Some of the
key players in the global lymphedema diagnostics market are Siemens
Healthineers, GE Healthcare, Stryker Corporation, Philips, Shimadzu
Corporation, Canon, Inc., United Imaging Healthcare Co., Ltd., Hitachi, Ltd.,
Fluoptics, and Esaote SPA.
Access
Report Details @ https://www.marketresearchfuture.com/reports/lymphedema-diagnostics-market-8761
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment